Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...
Recent reports have now implicated interleukin 12 and interleukin 23 ... The human monoclonal antibody ustekinumab blocks the biologic activity of IL-12 and IL-23 by inhibiting receptors of ...
GlobalData on MSN4d
Celltrion’s Avtozma receives FDA approval for multiple conditionsThe FDA's approval is grounded in an evidence totality and comprehensive data package, which includes outcomes from a study.
January started the year off strong, with several business updates, long-term clinical trial results on multiple biosimilars, ...
Activated macrophages engulf the microbiota and produce increased levels of interleukin-23 and interleukin-12 ... The monoclonal antibody ustekinumab can bind to the IL-12p40 subunit, interfering with ...
The three-signal paradigm tries to capture how the innate immune system instructs adaptive immune responses in three well-defined actions: (1) presentation of antigenic peptides in the context of MHC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback